Welcome to Immuno-Oncology – the online, open access, peer-reviewed journal with a translational focus.

Current issue

Apr 2022

Vol 3 Issue 03

Issue Spotlight: Optimizing clinical development strategy for the rapidly evolving I-O field

Issue Spotlight: Novel target and pathways: driving new approaches to tackling the TME and resistance to I-O therapeutics

View issue

Issue Spotlight: Dissecting investor and market access trends and drivers for I-O R&D insights

View issue

Issue Spotlights: Anticipating immuno-oncology modality/platform development trends for 2022 | Optimizing clinical development strategy for the rapidly evolving I-O field

View issue